| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Hohenleitner Susan | Chief Financial Officer | C/O ARDELYX, INC., 400 FIFTH AVE, SUITE 210, WALTHAM | /s/ Elizabeth Grammer, Attorney-in-Fact for Susan Hohenleitner | 23 Feb 2026 | 0002093095 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ARDX | Common Stock | Sale | $10,475 | -1,786 | -0.77% | $5.86 | 230,780 | 20 Feb 2026 | Direct | F1 |
| transaction | ARDX | Common Stock | Sale | $1,411 | -247 | -0.11% | $5.71 | 230,533 | 20 Feb 2026 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes. |